InBody

(주)인바디 · KOSDAQ · 041830 · Industry: Manufacture of other medical and surgical equipment and orthopedic appliances n.e.c.

Key metrics

Earnings

Revenue, Q3 2026₩71.3bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-2.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+19.2% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩19.3bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+8.9% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+96.5% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months9 As of Nov 19, 2026
DART filings, previous 3 months10 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Sep 17, 2026Cha In-jun (Registered director)Other (After-hours sell)-120,000 shares₩54,860₩6.6bn
May 21, 2026Bang U Seong (Registered director)Other (Treasury stock bonus)+300 shares——
Jan 1, 2026Kim Do-seong (Non-registered officer)Other (New appointment)+32 shares——Reported late

Annual financials

YearRevenueOperating income
2025₩233.9bn₩36.8bn
2024₩204.5bn₩36.7bn
2023₩170.4bn₩38.3bn

Filing timeline